U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco
Apogee Therapeutics, Inc. APGE | 90.68 90.68 | -0.20% 0.00% Post |
Darling Ingredients Inc DAR | 60.25 60.25 | -0.03% 0.00% Post |
Bunge Global SA BG | 125.77 125.77 | -0.05% 0.00% Post |
Archer-Daniels-Midland Company ADM | 69.43 69.43 | -0.57% 0.00% Post |
Lamb Weston Holdings, Inc. LW | 45.01 45.45 | +0.49% +0.98% Post |
March 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apogee Therapeutics, Insmed and Sunoco, on Tuesday.
HIGHLIGHTS
* Apogee Therapeutics Inc APGE.O: Stephens raises target price to $110 from $100 |
* Insmed Inc INSM.O: Leerink Partners raises target price to $215 from $210 |
* Sunoco LP SUN.N: JP Morgan raises target price to $73 from $66 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* ADM ADM.N: JP Morgan raises target price to $65 from $61 |
* Apogee Therapeutics Inc APGE.O: Stephens raises target price to $110 from $100 |
* Bunge BG.N: JP Morgan raises target price to $134 from $130 |
* Darling Ingredients Inc DAR.N: JP Morgan raises target price to $69 from $59 |
* Insmed Inc INSM.O: Leerink Partners raises target price to $215 from $210 |
* Lamb Weston Holdings Inc LW.N: JP Morgan cuts target price to $44 from $50 |
* Sunoco LP SUN.N: JP Morgan raises target price to $73 from $66 |